Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-17 | Amended | $110,895,239 | $14,989,380 | Equity Only | 06b | SEC link |
| 2023-09-18 | Amended | $95,905,859 | $32,100,359 | Equity Only | 06b | SEC link |
| 2023-06-09 | New | $63,805,500 | $63,805,500 | Equity Only | 06b | SEC link |
| 2022-08-22 | Amended | $23,413,102 | $8,487,000 | Other | 06b | SEC link |
| 2022-07-29 | New | $14,926,102 | $14,926,102 | Other | 06b | SEC link |
| 2022-02-18 | Amended | $34,614,335 | $14,864,151 | Equity Only | 06b | SEC link |
| 2020-07-15 | Amended | $19,750,184 | $3,497,005 | Equity Only | 06b | SEC link |
| 2019-11-19 | Amended | $16,253,179 | $12,879,171 | Equity Only | 06b | SEC link |
| 2019-09-23 | New | $3,374,008 | $3,374,008 | Equity Only | 06b | SEC link |
| 2016-05-02 | Amended | $10,919,000 | $715,000 | Equity Only | 06b | SEC link |
| 2016-04-12 | Amended | $10,204,000 | $1,877,500 | Equity Only | 06b | SEC link |
| 2016-03-23 | Amended | $8,326,500 | $5,429,000 | Equity Only | 06b | SEC link |
| 2016-02-24 | New | $2,897,500 | $2,897,500 | Equity Only | 06b | SEC link |
| 2016-02-23 | New | $300,000 | $300,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Nels Bergmark | Executive |
| Jamie Donadio | Executive |
| Carlos Guillem | Director |
| Alvaro Guillem | Director |
| Dale Jones | Director |
| Harpreet Kaur | Director, Executive |
| Jocelyn Keyser | Director |
| D. Jeffrey Keyser | Director, Executive |
| Jennifer D. Rasmussen | Director |
| Henrik Rasmussen | Director |
| Bhupinder Singh | Director, Executive |
| Frank Stonebanks | Director, Executive |